25May / 0 / CsfxUK competition regulator looking into $39 billion AstraZeneca-Alexion dealAstraZeneca (NASDAQ:AZN) is trading down 0.26% at 8129.00 Britain’s competition regulator is reviewing AstraZeneca (NASDAQ:AZN)’s $39 billion buyout of U.S.-based Alexion (NASDAQ:ALXN) on concerns it could reduce competition in the astrazeneca, AstraZeneca Share Price, AstraZeneca Stock Price, AstraZeneca Trade Ideas, COVID-19, COVID-19 pandemic, market news, Pfizer COVID, Pfizer COVID-19 vaccine, stock market news, Stock To Trade Trade Idea Stocks Read More
